Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07042451 · ClinicalTrials.gov registry record · NA
An Evaluation of the Pink Cloud Application in Post- Treatment Substance Use Disorder Support
A NA study of Substance Use, sponsored by Loyola Marymount University.
- Recruiting
- Registry status
- NA
- Development phase
- 1,410
- Enrollment target
- 1
- Study location
NCT07042451: Recruiting NA study of Substance Use, sponsored by Loyola Marymount University.
NCT07042451 is a NA study of Substance Use that is actively recruiting participants, run by Loyola Marymount University. The registered enrollment target is 1,410 participants, above the 1,244-participant average among 88 other Substance Use trials with a reported enrollment target (13% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07042451, a NA study of Substance Use, is actively recruiting participants, sponsored by Loyola Marymount University.
- RECRUITING
- Registry status
- NA
- Development phase
- 1,410 participants
- Enrollment target
- 1
- Study location
Study Summary
This randomized controlled trial (RCT) will evaluate the feasibility and efficacy of Pink Cloud, a mobile health application designed to support recovery from substance and alcohol use disorders (SUD/AUD). The app provides access to over 245,000 in-person and virtual 12-Step meetings, along with features such as a sobriety counter, daily planner, and personal inventory tools. In this study, 1,410 participants in various stages of recovery will be randomly assigned to receive either access to the Pink Cloud app or to a control condition. Participants will complete follow-up assessments at 1, 3, and 6 months. Primary outcomes include number of days sober and frequency of drug and alcohol problems. Secondary outcomes include meeting attendance, proportion of sober individuals in one's social network, and engagement in recovery-related activities. The investigators hypothesize that participants in the Pink Cloud group will report more days sober and fewer substance use problems than those in the control group, and that they will also report attending more meetings, having a greater proportion of sober peers, and engaging more frequently in recovery activities.
Primary Outcome
Self-reported number of days participant reports not using alcohol or drugs in the past 30 days.
Conditions Studied
Interventions
- BEHAVIORAL Active Control
- BEHAVIORAL Pink Cloud
Study Locations (1)
California
- Loyola Marymount - Los Angeles
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,410 participants |
| Start Date | 2025-07-09 |
| Est. Completion | 2026-08 |
| Phase | NA |
What NCT07042451 shows while recruiting
NCT07042451 is an interventional study that assigns participants to a tested intervention. Its 1,410 participants enrollment target places it among the larger protocols in the corpus, above the 1,244-participant average among 88 other Substance Use trials with a reported enrollment target (13% higher).
The record links to 1 condition, with Substance Use appearing as the primary indexed condition, and to 2 interventions - of which Active Control is the first listed.
NCT07042451 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT07042451 about?
NCT07042451 is a clinical study titled "An Evaluation of the Pink Cloud Application in Post- Treatment Substance Use Disorder Support". This randomized controlled trial (RCT) will evaluate the feasibility and efficacy of Pink Cloud, a mobile health application designed to support recovery from substance and alcohol use disorders (SUD/AUD). The app provides access to over 245,000 in-person and virtual 12-Step meetings, along with fea...
What is the current status of trial NCT07042451?
This trial is currently recruiting. It is a NA study. The enrollment target is 1,410 participants. The study started on 2025-07-09. Estimated completion is 2026-08.
What conditions does trial NCT07042451 study?
This clinical trial studies the following conditions: Substance Use.
What interventions are being tested in trial NCT07042451?
The interventions under investigation include: Active Control (BEHAVIORAL), Pink Cloud (BEHAVIORAL).
Who is sponsoring clinical trial NCT07042451?
This trial is sponsored by Loyola Marymount University, which has 7 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07042451 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Substance Use
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT07042451's enrollment target sits among peer trials
1,410 8th of 88 higher than 81 of 88 other Substance Use trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Substance Use trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Native Spirit: Significant Aim 3: Intervention
RECRUITING · NA
-
Parent SMART (Substance Misuse in Adolescents in Residential Treatment)
RECRUITING · NA
-
Cultural Adaptation of Drug Treatment for DJJ Youth
RECRUITING · NA
-
Adaptation and Evaluation of Bright Horizons
RECRUITING · NA
-
Teen Health Choices & Wellness
RECRUITING · NA
-
Pre-exposure Prophylaxis (PrEP) Uptake and Adherence Intervention for Women with Trauma-related Conditions
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05890404 · 1,410 participants · NA
SGM Evidenced-Based Mental Healthcare Implementation
- NCT07222566 · 1,410 participants · Phase 3
A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
- NCT05992935 · 1,405 participants · Phase 1
Study to Evaluate the Safety, Reactogenicity, and Immunogenicity of mRNA-1403 and mRNA-1405 to Prevent Norovirus Acute Gastroenteritis in Healthy Adults 18 to 80 Years of Age
- NCT05444582 · 1,404 participants · Phase 4
Levonorgestrel 52 mg IUD for Emergency Contraception and Same-Day Start
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI